[PLX] YoY Quarter Result on 31-Mar-2019 [#Q1]

Stock
[PLX] Protalix BioTherapeutics, Inc.
Announcement Date
06-May-2019
Financial Year
2019
Quarter
31-Mar-2019 [#Q1]
Profit Trend
QoQ- -174.27%
YoY- 22.72%
Quarter Report
PLX's Result
PLX's Financial Summary
View:
Show?
Quarter Result
31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 CAGR
Revenue 16,085 11,320 21,646 10,439 4,553 2,889 679 69.42%
PBT -2,286 -5,475 1,667 -7,264 -9,400 -59,148 -8,526 -19.69%
Tax 416 2,207 203 190 132 2,087 314 4.79%
NP -2,702 -5,475 1,667 -7,264 -9,400 -59,148 -8,598 -17.53%
Tax Rate - - -12.18% - - - - -
Total Cost 18,787 16,795 19,979 17,703 13,953 62,037 9,277 12.47%
Ratio Analysis
31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 CAGR
NP Margin -16.80 -48.37 7.70 -69.59 -206.46 -2,047.35 -1,266.27 -51.32%
Per Share
31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 CAGR
EPS -0.06 -0.14 0.10 -0.49 -0.65 -4.75 -0.09 -6.53%
EPS Diluted -0.06 -0.14 0.10 -0.49 -0.65 -4.75 -0.09 -6.53%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.